The tradeoff is more side effects early on, which is why the escalation schedule exists
43% of adults who have diabetes say they have used GLP-1 medications
Secondary carnitine deficiency Secondary carnitine deficiency, which manifests with a decrease of carnitine levels in plasma or tissues, may be associated with genetically determined metabolic conditions, acquired medical conditions, or iatrogenic states
2019 Nov;29(11):1151-1167
BPC-157 + TB-500 Peptide Blend Synthesized and Lyophilized in Canada by Koi Peptides Domestic Co-Lyophilization at a Canadian Facility BPC-157 and TB-500 are produced on independent solid-phase peptide synthesis runs at Koi's Canadian production partner, each purified to clear the 99% specification before being combined at a 1:1 mass ratio for a single co-lyophilization cycle
These models exclude taxes, any shipping charge, and the separate official Zepbound page's $499 high-dose price